Organization Profile
The Accelerated Cure Project for Multiple Sclerosis (ACP) is a nonprofit organization dedicated to accelerating research to improve diagnosis, optimize treatment, and ultimately cure multiple sclerosis (MS). Founded in 2001 by a person living with MS, ACP was built on the belief that research advances fastest when scientists have access to the data, biospecimens, and patient insights needed to answer the most important questions in the field.
ACP serves the global MS research community through a portfolio of resources designed to advance discovery and collaboration. These include the ACP Repository, a collection of highly characterized biospecimens and clinical data from more than 3,200 participants, and iConquerMS™, a people-powered research network of more than 8,500 individuals affected by MS who contribute their experiences, health information, and perspectives to guide research priorities.
A core focus of ACP's work is ensuring that research reflects the diversity of the MS community. Through initiatives such as the MS Minority Research Engagement Partnership Network and the Research Inclusion, Diversity, and Equity Council, ACP works to identify and address barriers to research participation among historically underserved populations.
At ACP, people affected by MS are partners in the research process. By bringing together patients, caregivers, clinicians, researchers, industry, and advocacy organizations, ACP helps ensure that research is relevant, inclusive, and positioned to improve the lives of everyone affected by MS.
